Courtney D. DiNardo is an Associate Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Dr. DiNardo is a clinical researcher with a specialized focus on prognostication and personalized therapeutics for patients with myeloid malignancies. She has completed formal training in epidemiology and biostatistics, with a Master's of Science in Clinical Epidemiology (2012). She is the principal investigator for multiple novel therapeutic agents currently in clinical trial and was involved in the clinical development of venetoclax for myeloid malignancies.
Dr. DiNardo is an internationally recognized researcher and clinician and serves on the AAMDSIF Patient Education Council.
Dr.DiNardio will provide a thorough review of the most important papers and studies presented at the 62nd American Society of Hematology Annual Meeting for patients with MDS and AML. The presentation will be made in lay language so it is accessible for patients and families.
Participants will have an opportunity to ask questions via the text chat window. Those who are joining via telephone are invited to submit their questions to firstname.lastname@example.org in advance of the webinar.
Thank you for registering for "ASH 2020: MDS and AML Updates", March 8, 2020 at 2pm Central/ 3pm Eastern.
You will receive an email with a registration confirmation including the webinar link
and a call-in phone # for those participating via telephone. If you do not receive the link,
please check your Spam/Junk folders.
If you have not received a registration confirmation, please email email@example.com
or call (800) 747-2820 x2 no later than 30 minutes before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 2 - 3 business days on the AAMDSIF website.